Initial results of pulmonary resection following neoadjuvant nivolumab in patients with resectable non-small cell lung cancer

OBJECTIVE: We conducted a phase I trial of neoadjuvant nivolumab, a monoclonal antibody to the PD-1 checkpoint receptor, in patients with resectable non-small cell lung cancer (NSCLC). We analyzed perioperative outcomes to assess the safety of this strategy. METHODS: Patients with untreated stage I-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Cardiovasc Surg
Autors principals: Bott, Matthew J., Yang, Stephen C., Park, Bernard J., Adusumilli, Prasad S., Rusch, Valerie W., Isbell, James M., Downey, Robert J., Brahmer, Julie R., Battafarano, Richard, Bush, Errol, Chaft, Jamie, Forde, Patrick M., Jones, David R., Broderick, Stephen R.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653596/
https://ncbi.nlm.nih.gov/pubmed/30718052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.11.124
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars